chlorpromazine and 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline

chlorpromazine has been researched along with 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gigler, G; Gyertyán, I; Simó, A	1

Other Studies

1 other study(ies) available for chlorpromazine and 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline

Article	Year
The neuroprotective and hypothermic effect of GYKI-52466, a non-competitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-antagonist on histological and behavioural variables in the gerbil global ischemia model. Brain research bulletin, 1999, Volume: 50, Issue:3 Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Body Temperature; Chlorpromazine; Excitatory Amino Acid Antagonists; Gerbillinae; Ischemic Attack, Transient; Male; Maze Learning; Motor Activity; Neuroprotective Agents; Quinoxalines; Receptors, AMPA; Time Factors	1999

Article

Year

The neuroprotective and hypothermic effect of GYKI-52466, a non-competitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-antagonist on histological and behavioural variables in the gerbil global ischemia model.

Brain research bulletin, 1999, Volume: 50, Issue:3

Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Body Temperature; Chlorpromazine; Excitatory Amino Acid Antagonists; Gerbillinae; Ischemic Attack, Transient; Male; Maze Learning; Motor Activity; Neuroprotective Agents; Quinoxalines; Receptors, AMPA; Time Factors

1999